Oncoshot has announced it will be welcoming Dr Bernard Ng, Chief Scientific Officer of Milltrust Ventures, to its advisory board this month. This comes as a first step as the specialist investment organization finances the fast-growing health tech company founded in Singapore.
Milltrust Ventures is a subsidiary of Milltrust International Group, a specialist investment organization co-headquartered in the asset management hubs of London and Singapore. It invests in early-stage high-potential companies with a focus on science and technology that can positively impact individual health and healthcare systems. Milltrust Ventures screens and identifies start-ups from the British and European ecosystems, and Asia, particularly Singapore, home to a thriving start-up ecosystem with strong backing and support from good policies and government assistance.
